MARIZYME, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Marizyme, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Marizyme, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.96M, a 92.6% increase year-over-year.
  • Marizyme, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$19.1M, a 78.4% increase year-over-year.
  • Marizyme, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$69.5M, a 82.2% decline from 2022.
  • Marizyme, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.2M, a 247% decline from 2021.
  • Marizyme, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$11M, a 88.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19.1M -$1.96M +$24.6M +92.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-03-05
Q2 2024 -$43.7M -$7.44M +$28.6M +79.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-03-05
Q1 2024 -$72.4M -$5.4M -$2.84M -111% Jan 1, 2024 Mar 31, 2024 10-Q 2025-03-05
Q4 2023 -$69.5M -$4.35M +$19.2M +81.5% Oct 1, 2023 Dec 31, 2023 10-K/A 2025-02-06
Q3 2023 -$88.7M -$26.5M -$25M -1610% Jul 1, 2023 Sep 30, 2023 10-Q 2025-03-05
Q2 2023 -$63.8M -$36.1M -$29.2M -421% Apr 1, 2023 Jun 30, 2023 10-Q 2025-03-05
Q1 2023 -$34.6M -$2.55M +$3.57M +58.3% Jan 1, 2023 Mar 31, 2023 10-Q 2025-03-05
Q4 2022 -$38.2M -$23.6M -$18M -327% Oct 1, 2022 Dec 31, 2022 10-K/A 2025-02-06
Q3 2022 -$20.1M -$1.55M +$79.4K +4.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$20.2M -$6.92M -$5.29M -322% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$14.9M -$6.12M -$3.91M -177% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$11M -$5.52M -$2.64M -91.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$8.36M -$1.63M +$433K +21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.79M -$1.64M -$1.2M -277% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$7.59M -$2.21M -$1.74M -369% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$5.85M -$2.87M -$2.61M -997% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$3.23M -$2.07M -$1.56M -306% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$1.68M -$435K -$198K -83.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 -$1.48M -$471K -$421K -838% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 -$1.06M -$262K -$200K -322% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$858K -$509K -$436K -598% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-24
Q2 2019 -$422K -$237K -$171K -260% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$251K -$50.3K -$2.29K -4.77% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$249K -$62K +$575K +90.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-15
Q3 2018 -$824K -$72.8K -$112K -284% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$711K -$65.9K -$73.4K -980% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-03
Q1 2018 -$638K -$48K -$67.2K -349% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$571K -$637K +$129K +16.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$700K $39.6K +$55.6K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$755K $7.49K +$32.5K Apr 1, 2017 Jun 30, 2017 10-K/A 2018-06-27
Q1 2017 -$788K $19.3K +$85K Jan 1, 2017 Mar 31, 2017 10-K/A 2018-06-27
Q4 2016 -$873K -$766K Oct 1, 2016 Dec 31, 2016 10-K/A 2018-11-28
Q3 2016 -$16K Jul 1, 2016 Sep 30, 2016 10-K/A 2018-06-27
Q2 2016 -$25K Apr 1, 2016 Jun 30, 2016 10-K/A 2018-06-27
Q1 2016 -$65.7K Jan 1, 2016 Mar 31, 2016 10-K/A 2018-06-27
Q4 2013 -$2.43M $242K +$3.73M Oct 1, 2013 Dec 31, 2013 10-K/A 2018-11-28
Q3 2013 -$6.16M -$1.14M -$747K -191% Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-05-15
Q2 2013 -$5.41M -$200K +$1.17M +85.4% Apr 1, 2013 Jun 30, 2013 10-Q/A 2013-08-22
Q1 2013 -$6.58M -$1.33M +$243K +15.4% Jan 1, 2013 Mar 31, 2013 10-Q/A 2013-08-15
Q4 2012 -$6.83M -$3.49M +$5.43M +60.9% Oct 2, 2012 Dec 31, 2012 10-K/A 2014-05-08
Q3 2012 -$12.3M -$391K +$1.61M +80.4% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-05-15
Q2 2012 -$13.9M -$1.37M -$1.98M -326% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-22
Q1 2012 -$11.9M -$1.58M -$849K -117% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-08-15
Q4 2011 -$11M -$8.92M -$8.87M -16650% Oct 1, 2011 Dec 31, 2011 10-K/A 2014-05-08
Q3 2011 -$2.17M -$2M -$1.53M -324% Jul 1, 2011 Sep 30, 2011 10-Q/A 2013-07-19
Q2 2011 -$646K $607K +$1.32M Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-07-18
Q1 2011 -$1.97M -$728K Jan 1, 2011 Mar 31, 2011 10-K 2012-07-16
Q4 2010 -$53.3K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-03-23
Q3 2010 -$471K Jul 1, 2010 Sep 30, 2010 10-Q/A 2013-07-19
Q2 2010 -$713K Apr 1, 2010 Jun 30, 2010 10-Q/A 2013-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.